$RDCM

RADCOM LTD

No enriched coverage for $RDCM in the last 7 days.

No SEC Form 4 filings for $RDCM in the last 30 days.

Med

Radcom (RDCM) Net Margin Expansion To 17.2% Reinforces Bullish Community Narrative

Radcom (RDCM) reported Q1 2026 revenue of US$18.6 million and basic EPS of US$0.18, with a significant net margin expansion to 17.2%. While the company's earnings growth of 46.1% over the past year is strong, its revenue growth of 8.9% trails the broader US market rate of 11.6%, shifting the bullish narrative towards profitability rather than top-line pace. Despite a P/E ratio below industry averages and a valuation gap to its DCF fair value, the slower revenue growth presents a point for bearish critiques.

RADCOM LTD SEC Filing

This SEC Form 144 filing for RADCOM LTD (RDCM) reveals multiple large open-market sales of Ordinary Shares by Lynrock Lake Master Fund LP between April 23, 2026, and May 11, 2026. The filing details numerous transactions, including a sale of 34,677 shares for $559,862.49 on May 8, 2026, indicating routine resale notices by a significant holder. The document includes key figures, definitions related to Rule 144 and ordinary shares, and a comprehensive list of sales by Lynrock Lake Master Fund LP.

Radcom Q1 Preview: Slowing Down Growth, But Risk-To-Reward Is Enticing (Rating Upgrade)

Radcom Ltd. (RDCM) has been upgraded to a buy ahead of its Q1 earnings report, with a fair value estimated at $21 per share. Despite slowing revenue growth, the company consistently beats expectations, and the launch of its Neura agentic AI suite is seen as a key growth catalyst. The article highlights an enticing risk-reward profile, though notes potential volatility and the need for new Tier-1 operator wins.